ArticleMedicine2016

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.

Wey-Ran Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.